Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory IPA”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Testing effectiveness (Phase 2)Study completedNCT00871377
What this trial is testing

Double Blind, Crossover Study of Fish Oil [EPA and DHA] for Intractable Partial Seizures

Who this might be right for
Epilepsy
National Center for Complementary and Integrative Health (NCCIH) 24
Large-scale testing (Phase 3)Ended earlyNCT05238116
What this trial is testing

Safety and Efficacy of PC945 (Opelconazole) in Combination With Other Antifungal Therapy for the Treatment of Refractory Invasive Pulmonary Aspergillosis (OPERA-T Study)

Who this might be right for
Refractory IPA
Pulmocide Ltd 85
Large-scale testing (Phase 3)Study completedNCT03059992
What this trial is testing

Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment

Who this might be right for
Invasive CandidiasisMucocutaneous CandidiasisCoccidioidomycosis+7 more
Scynexis, Inc. 233